Thomas Klonisch is a highly accomplished medical
professional who has dedicated his career to understanding and treating adult
brain tumors. He received his M.D. and Ph.D. from Justus Liebig University of
Giessen in Germany. He received his certification as an Anatomist by the German
Anatomical Society in 1999 and completed his Habilitation at Martin Luther
University of Halle-Wittenberg in 2000. In 2004, he became a Full Professor and
Head of the Department of Human Anatomy and Cell Science at the University of
Manitoba, Winnipeg, MB, Canada. He founded the Brain Tumor Research Alliance
Manitoba (BTRAM) at the Faculty of Health Sciences, University of Manitoba, and
is an Adjunct Scientist at CancerCare Manitoba. His research explores novel
experimental drugs that target cancer cells directly and/or enhance immune
responses against cancer cells in an effort to find more effective anticancer
therapies.
Thomas Klonisch is a highly accomplished medical
professional who has dedicated his career to understanding and treating adult
brain tumors. He received his M.D. and Ph.D. from Justus Liebig University of
Giessen in Germany. He received his certification as an Anatomist by the German
Anatomical Society in 1999 and completed his Habilitation at Martin Luther
University of Halle-Wittenberg in 2000. In 2004, he became a Full Professor and
Head of the Department of Human Anatomy and Cell Science at the University of
Manitoba, Winnipeg, MB, Canada. He founded the Brain Tumor Research Alliance
Manitoba (BTRAM) at the Faculty of Health Sciences, University of Manitoba, and
is an Adjunct Scientist at CancerCare Manitoba. His research explores novel
experimental drugs that target cancer cells directly and/or enhance immune
responses against cancer cells in an effort to find more effective anticancer
therapies.